Viktoria Schreiner

Viktoria Schreiner is a highly experienced pharmaceutical scientist with a strong background in formulation development for parenteral drug products. Currently serving as Principal Scientist and Group Lead at Lonza since October 2020, Viktoria oversees the design and execution of formulation studies for biologics. Prior experience includes a PhD role at Universität Basel, focusing on controlled release formulations and pharmacokinetics, as well as research positions at the University of Florida and Boehringer Ingelheim, where Viktoria contributed to the development and characterization of inhalable and solid dispersion formulations. Viktoria holds a PhD in Pharmaceutical Sciences from the University of Basel and a Staatsexamen in Pharmacy from The University of Bonn.